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Although the COVID-19 response is ongoing and contexts are constantly evolving, the purpose of the
following research paper is to flag lessons learnt from the Covid-19 pandemic to assist PSI staff and
affiliates in formulating policies for healthcare systems and their supply chains.
The paper builds on research done by a team of researchers at Public Services International Research
Unit (PSIRU) for Public Services International (PSI) in 2020, available online in two working papers at
the University of Greenwich. The ongoing research investigates what factors and policies have4
helped or hindered protection against Covid-19 as well as support for economic well-being and the
environment. It analyses the unequal impact of the pandemic, the policies, and the role of business
interests during the pandemic.
This is the third paper in a series on lessons from Covid-19. The first is a paper on the key lessons from
Covid-19; the second is about why countries expected to succeed did badly. There will be a
forthcoming paper on Covid-19 and economic recovery.
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Lesson 1: Capacity building by training and employing workers directly
Building public healthcare capacity
Public health systems need sufficient trained workers to provide services, including the public health
functions necessary to deal with unforeseen epidemics. The experience with Covid-19 has
demonstrated once again that public sector institutions with direct permanent employees are the
most reliable way of ensuring adequate capacity, and that outsourcing creates problems of poor
coordination and performance. Government as a whole also depends on reliable directly employed
civil servants to provide policy advice without distortion by private interests.
A new report from UNDP and UCL academics makes strong recommendations that governments
should:
“Build institutions that enable the implementation of resilience-driven developmental
plans…. Build in-house capabilities and skills focused on adaptability and learning….”. It
refers to the success of the Indian state of Kerala in controlling the epidemic, as based on
long-term commitment to public education and participatory government, and also “the
institutional memory from the successful management of two major floods and an outbreak
of a virus in 2018 resulted in a series of effective emergency management protocols that
have become baked into the way government works.” 5
Country examples:
This capacity of public healthcare systems enabled countries as diverse as Germany, South Korea,
Vietnam, and Rwanda to control the first waves of the epidemic effectively.6
● Rwanda, a low income country, nevertheless managed to keep the Covid mortality rate low
because it “provides nearly universal health care to its 13 million citizens. All the testing and
treatment for the virus is provided free of charge, health workers call or visit every potential
contact of someone who has tested positive…. medical staff started screening at border
entry points and nationwide testing was implemented almost a month before the first case
was registered… which also triggered a systematic tracing campaign utilising community
health-care workers, police and college students”. 7
7 Mazzucato, Mariana, Rainer Kattel, Giulio Quaggiotto, and Milica Begovic. 2021. ‘COVID-19 and the Need for
Dynamic State Capabilities’: UNDP DEVELOPMENT FUTURES SERIES WORKING PAPERS.
https://www.ucl.ac.uk/bartlett/public-purpose/news/2021/may/iipp-and-undp-publish-new-report-covid-19-a
nd-need-dynamic-public-sector-capabilities.
6 Mazzucato, Mariana, and Rainer Kattel. 2020. ‘COVID-19 and Public-Sector Capacity’. Oxford Review of
Economic Policy 36 (Supplement_1): S256–69. https://doi.org/10.1093/oxrep/graa031.
5 Mazzucato, Mariana, Rainer Kattel, Giulio Quaggiotto, and Milica Begovic. 2021. ‘COVID-19 and the Need for




● By contrast, the UK had cut back the public health capacity of the NHS, and sought to rely on
outsourcing to deal with the pandemic, with very poor results.8
● Like other countries, the pandemic has forced Peru to make big short-term increases in the
number of workers dealing with the pandemic. Through temporary employment, one-off
payments, collaboration with university staff, volunteers, and outsourcing. International
researchers argue that this creates an opportunity for Peru to permanently employ these
staff and develop capacity through “a longer-term planning perspective based on
understanding the likely skills requirement of health systems and developing this type of
health and care provision policy”.9
● South Africa has committed to rebuilding state capacity, staffed by permanent directly
employed professional civil servants, reversing a policy of using external consultants such as
McKinseys. President Ramaphosa ha said: “We want to focus on professionalising the public
service, bringing in more qualified young people …. we’ve seen how outsourcing has
weakened our state and how those entities we tended to outsource to were themselves
captured and deeply involved in the challenges that we had to face of corruption… Through
that, the financial capability was weakened. … The accountability and discipline that is
needed immediately just goes down and there is a loss of focus.” 10
Conditions of employment
The pandemic has shown that decent pay and conditions for public service workers should be
treated as key investment in public service capacity and employment. This is particularly clear in
relation to some specific conditions such as the right of workers to proper PPE protection , and paid11
sick leave.
● Workers and pay as public investments
In the USA, President Biden’s American Jobs Plan in March 2021, treats good pay, conditions and
union rights as a core part of investments in public services: “Our workers will … be trained for
well-paying… good-quality jobs that pay prevailing wages in safe and healthy workplaces while
ensuring workers have a free and fair choice to organize, join a union, and bargain collectively with
11 Graham, Luke D. 2021. ‘The Right to Clothing and Personal Protective Equipment in the Context of COVID-19’.
The International Journal of Human Rights 0 (0): 1–20. https://doi.org/10.1080/13642987.2021.1874939.
10 Meiring, Pieter. 2021. ‘Government to Rebuild State Capability’. Cape Business News (blog). 25 March 2021.
https://www.cbn.co.za/featured/government-to-rebuild-state-capability/.
9 Rees, Gareth H., Felipe Peralta Quispe, and Cris Scotter. n.d. ‘The Implications of COVID-19 for Health
Workforce Planning and Policy: The Case of Peru’. The International Journal of Health Planning and
Management n/a (n/a). Accessed 7 April 2021. https://doi.org/10.1002/hpm.3127.




their employers.” The AJP also emphasises the equality impact of such a policy, stating that12
workers in care homes “the majority of whom are women of colour – have been underpaid and
undervalued for too long.” The USA government also proposed in April 2021 to introduce for the13
first time a legal right to paid leave for sickness and family reasons, but this will take years to
implement. (But it is nevertheless far better than the hopelessly weak guidance still being issued14
by the ILO and WHO in 2021, which just calls for employers to ‘establish flexible sick leave policies’,
and for workers to ‘stay home if unwell’. ).15
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‘FACT SHEET: The American Jobs Plan’. 2021. The White House. 31 March 2021.
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an-jobs-plan/.
15 ‘COVID-19: Occupational Health and Safety for Health Workers’. 02 Feb 2021.
https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-HCW_advice-2021.1.
14 Zhou, Li. 2021. ‘This Could Be the Year Federal Paid Leave Finally Passes’. Vox. 28 April 2021.
https://www.vox.com/2021/4/28/22405362/joe-biden-paid-leave-american-families-plan.
13 ‘FACT SHEET: The American Jobs Plan’. 2021. The White House. 31 March 2021.
https://www.whitehouse.gov/briefing-room/statements-releases/2021/03/31/fact-sheet-the-american-jobs-pl
an/.




Lesson 2: Develop local public control over services and production of key supplies
Countries which relied on emergency outsourcing to private contractors for public health functions
to test and track infected people have experienced disastrous levels of inefficiency and
incompetence. Nearly all countries have suffered problems with inability to get key supplies, such as
personal protective equipment (PPE). And many countries have come to realise the limited technical
options available from manufacturers of medical equipment such as ventilators.
In the words of a UNDP/UCL report, countries “have been largely constrained in their options by
previous investments (or lack thereof) in core services and capacity building.” What is needed is16
adequate public sector capacity to ensure the supply of these necessary goods and services: to
“support the creation or conservation of industrial commons, that is, the knowledge and capacities
lost through outsourcing and offshoring”.17
The supreme negative experience in this respect was the UK, where the government
outsourced every possible part of the new resources needed to control the Covid19
epidemic, instead of strengthening the capacity of the NHS. This includes PPE, testing,
tracking and tracing, and led to repeated problems:
o the warehouse stockpiling PPE for just such an emergency was unable to deliver to
hospitals, with workers describing the system as ‘chaotic’ and insufficient, out of date
stock.
o The government gave an emergency contract to Deloitte to sort out the system, but this
was described even by suppliers as a “disaster”, with Deloittes trying to source PPE from
China and ignoring offers from local communities, universities and small businesses in
the UK, who all reacted rapidly to offer to start producing PPE locally.
o A new system to supply PPE to care homes and GPs was outsourced to a company whose
CEO is a leading donor and supporter of the Conservative Party: but the system was too
slow, and care homes and councils were still “not able to access sufficient supplies of
PPE”.
o Contracts to operate drive-through coronavirus testing centres were awarded without
competition to Deloitte, which sub-contracted other outsourcing specialists Serco, Mitie,
G4S and Sodexo to manage the centres. These arrangements have failed, with the
centres being reported as “too far away”, the wrong tests being sent out, results being
lost and others being sent to the wrong person.
o The track and trace work in England has been outsourced to Serco, under yet another
uncompetitive contract, which Serco hope will “cement the position of the private
17 Jan Grumiller / Hannes Grohs. 2021. ‘Increasing Security of Supply for Critical Medical and Pharmaceutical
Goods in the EU: Lessons from the COVID-19 Pandemic’. Briefing Paper 29. Vienna: OFSE.
https://www.oefse.at/en/publikationen/detail/publication/show/Publication/critical-medical-and-pharmaceuti
cal-goods-in-the-eu/.
16 Mazzucato, Mariana, Rainer Kattel, Giulio Quaggiotto, and Milica Begovic. 2021. ‘COVID-19 and the Need for




sector” in the NHS. This too has proved a disaster, failing to contact thousands of people
in the worst-affected areas, while ignoring the potential role of local councils.
o The government issued a contract for a tracking app to a software firm with links to the
prime ministers special adviser. The app failed to work, and has been cancelled.18
Lesson 2.1 Develop local public control over test, track and trace (TTT)
Countries could control the pandemic much more effectively where they had built and maintained
sufficient local public health capacity to operate systematic test, track and trace (TTT) of infections.
● It was this existing public capacity which enabled Singapore and South Korea to deploy
digital tracking applications, and for Germany and South Korea to operate high levels of rapid
testing through their existing public laboratories, supplied with the required safety
equipment and chemicals by established local producers.19
● Thailand managed TTT very effectively, partly because its healthcare system has a “long-term
strategy to boost its public health function and has invested in field epidemiologists since
1980”. This includes the building of laboratory capacity in every part of the country, with a
target of establishing at least one laboratory with capacity for 10 000 RT-PCR tests per day in
each of its 77 provinces. In April 2020, 80 certified laboratories were already available – 39 in
Bangkok and 41 elsewhere – and by June a further 30 laboratories had been set up, with 12
regional laboratories providing back-up testing with a turnaround time of 24 hours for those
provinces still without their own lab. The Maldives was helped by the WHO to extend20
laboratory facilities, train staff, set up quality assurance, and supply test kits, so that the
country can analyse 700 tests per day.21
Lesson 2.2: Develop local public control local/public sourcing of equipment e.g. PPE, tests,
equipment
The pandemic has also showed the problems of dependency on global supply chains based on ‘just in
time’ manufacturing and delivery for vital supplies such as PPE, and the limitation of depending on
commercial interests for designing and manufacturing key equipment, such as ventilators.
21 ‘WHO Helps Maldives Build Laboratory Capacity to Test COVID-19’. n.d. Accessed 23 April 2021.
https://www.who.int/southeastasia/news/feature-stories/detail/who-helps-maldives-build-laboratory-capacity
-to-test-covid-19.
20 COVID-19 Health System Response Monitor THAILAND September 2020
https://apps.who.int/iris/handle/10665/334146
19 Mazzucato, Mariana, and Rainer Kattel. 2020. ‘COVID-19 and Public-Sector Capacity’. Oxford Review of
Economic Policy 36 (Supplement_1): S256–69. https://doi.org/10.1093/oxrep/graa031
18 Nguyen, T.,Weghmann, V. and Hall, D.  (2020) COVID-19: Country case studies Mapping COVID: PSIRU working
papers for PSI. [Working Paper]. Available at: https://gala.gre.ac.uk/id/eprint/32127/ ; ‘Privatised and
Unprepared: The NHS Supply Chain’. 2020. We Own It. 18 May 2020.
https://weownit.org.uk/privatised-and-unprepared-nhs-supply-chain.
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Governments now recognise the need to increase stockpiles of vital equipment and medicines and
develop public sector, or at least local, capacity to manufacture such items.
Global supply chains failed to provide enough PPE for China at the start of the pandemic in Jan/Feb
2020, so China responded by using state-owned enterprises (SOEs) to produce materials, masks and
gloves in the quantities required. The USA got masks and PPE from China because China had
controlled the virus early and so had capacity for exports: “China’s rapid recovery was hence a stroke
of luck for the US in those products”. The clear solution to avoid future problems with supply chains22
is “a shift to nationalized production.” 23
● The USA has learned the lesson of Covid: president Biden’s ‘American jobs plan’ announced
in March 2021 includes building capacity to: “Protect Americans from future pandemics. ….
through major new investments in medical countermeasures, manufacturing; research and
development…. investments to shore up our nation’s strategic national stockpile; accelerate
the timeline to research, develop and field tests and therapeutics for emerging and future
outbreaks…. train personnel for epidemic and pandemic response; and onshore active
pharmaceutical ingredients” China’s new 5-year plan also pays attention to the problem24
of global supply chains and the need to ensure local sourcing of key supplies:25
Public sector capacity is also important in designing and manufacturing key medical equipment, and
can do so more rapidly than commercial developers.
● Public sector university engineers in the UK have played a vital and rapid role in
manufacturing new and better equipment for treating Covid patients, and made the
technology freely available globally. In March 2020, as the UK was experiencing the first wave
of Covid, intensive therapy units in NHS hospitals were being overwhelmed by the number of
patients needing ventilators. Engineers at University College London (UCL), working with
doctors at their sister hospital UCLH, and with engineers at Mercedes Power Trains with
whom the university already had working relations, realised that a simpler and less intrusive
breathing aid, known as a CPAP , which does not require intubation and oxygen supplies26
under intensive pressure, could be modified to help many Covid patients. It took the
engineers just 4 days from the initial meeting to develop the device so it could be mass
manufactured for treating Covid patients. The plans and details required to make the device
were also made available for every country in the world to download at no cost: within just
two days, nearly 700 requests to access the information, from governments, health
professionals, non-profits, and research institutes in 25 countries, had been approved. The
26 Continuous Positive Airway Pressure
25 ‘China: Report on the Work of the Government’. 2021.
http://english.www.gov.cn/premier/news/202103/13/content_WS604b9030c6d0719374afac02.html.
24 ‘FACT SHEET: The American Jobs Plan’. 2021. The White House. 31 March 2021.
https://www.whitehouse.gov/briefing-room/statements-releases/2021/03/31/fact-sheet-the-american-jobs-pl
an/.
23 Dallas, Mark P., Rory Horner, and Lantian Li. 2021. ‘The Mutual Constraints of States and Global Value Chains
during COVID-19: The Case of Personal Protective Equipment’. World Development 139 (March): 105324.
https://doi.org/10.1016/j.worlddev.2020.105324.
22 Hitt, Michael A., R. Michael Holmes, and Jean-Luc Arregle. 2021. ‘The (COVID-19) Pandemic and the New
World (Dis)Order’. Journal of World Business, March, 101210. https://doi.org/10.1016/j.jwb.2021.101210.
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CPAPs have been widely used in the UK, Italy, China and India, and reduced the demand for
ventilators and intensive care by as much as 50%. 27
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Lesson 3: Public funding and solidarity for vaccine R&D, production and distribution
Covax versus market power
Covax was set up in 2020 to ensure fair access to vaccines across the globe. Covax is co-led by the
WHO, the Global Vaccine Alliance (Gavi) and the Coalition for Epidemic Preparedness Innovations
(Cepi), and Unicef is a as key implementation partner. So far around 50 million vaccine doses have
been delivered through Covax. However, by April 2021 only 0.3% of the vaccines administered28
around the world had gone to people in low-income countries. Due to vaccines monopolies the
vaccine prises are too high for many countries around the world. For example, Oxfam research shows
the price Uganda paid for its vaccines so far means that to vaccinate the entire country is double of
the country’s entire healthcare budget.
Through advanced purchase commitments, many high-income countries have prioritised vaccinating
their own populations undermining a more holistic approach of protecting the most vulnerable
people around the world.
Intellectual Property Rights
The World Trade Organization longstanding agreement designed to protect intellectual property,
known as the Trade-Related Aspects of Intellectual Property Rights, or Trips, prevents countries to
produce and use all anti COVID-19 technologies. India and South Africa are advocating for a Trips29
waiver. Richer nations have so far opposed this waiver, yet the US recently changed position and
declared its support for a patent waiver. By the time of writing (early May 2021) the European Union
and Switzerland are, however, still resisting the Trips waiver.30
Without public funding no vaccines
In the debate on public property rights around vaccines is often forgotten that vaccine development
is based on government funding. It is public sector funding that allows the business of vaccine to
operate, as the private sector finds it too risky. During the Covid-19 pandemic the unprecedented
public funding helped companies to develop vaccines in less than a year.
There is a high degree of secrecy over the prices of vaccines, the risk of a high degree of abuse over
pricing or unfair pricing is high. Companies want to play countries of against each other, so aren’t
very incentivised of making the contracts transparent, and democratic governments do not want
their public to know if they had a bad deal or rival countries had a better deal.
Country examples of international vaccine rollout
The Serum Institute of India (SII) is the worlds’ largest vaccine producer by volume. In 2020 the SII
agreed to supply an initial 200 million vaccine doses to Covax to ensure availability to low and middle
income countries. The SII was expected to deliver the first 100 million doses between February and
30 Borger, J. (5 May 2021) US declares support for patent waiver on Covid-19 vaccines. The Guardian. Available at:
https://www.theguardian.com/world/2021/may/05/us-declares-support-for-patent-waiver-on-covid-19-vaccines
29 Kuchler, H. (7 May 2021) Will a suspension of Covid vaccine patents lead to more jabs? The Financial Times. Available at:
https://www.ft.com/content/b0f42409-6fdf-43eb-96c7-d166e090ab99
28 BBC (4 May 2021) Covax: How will Covid vaccines be shared around the world? BBC. Available at:
https://www.bbc.co.uk/news/world-55795297
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May. But India who is currently suffering from a severe Covid outbreak so far (by May 2021) only
delivered 30 million (this includes 10 million set aside for India itself under Covax).31
Cuba is in the process of developing two vaccines. Venezuela has begun clinical trials of the Cuban32
coronavirus vaccine candidate and plans to produce enough doses locally to vaccinate four million
people.
The UK decided before the pandemic to create a large new public sector capacity for manufacturing
vaccines because it recognised the inadequacy of the private sector.
The same vulnerabilities have already been seen in widespread and repeated shortages of medicines
including “medicines for cancer treatments, heart disease, nervous system disorders, hypertension,
as well as antibiotics and vaccines” which have increased exponentially in OECD countries alone in
the last 20 years, the major structural cause of which is “globalized and decentralized production
networks”
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